By Kuda Pembere Having received 2000 doses of Cabotegravir (CAB-LA), a long-acting injectable pre-exposure prophylaxis (PrEP), Zimbabwe’s Ministry of Health and Child Care says they will roll it out next year. Speaking at a Health Communicators Forum (HCF) media science café, a MoHCC officer in the AIDS and TB department Dr Idah Moyo said the product is currently being assessed at demonstration sites in the country. So of note is that the Cabotegravir long-acting injection pre-exposure prophylaxis is being delivered under the demonstration site and is coming in according to…
Read MoreMinistry of Health Speaks On Injectable PrEP Roll-Out in Zimbabwe
